Influenza Matrix Peptide (FluM1 58-66) is an epitope from the influenza A matrix protein used extensively in T-cell immunology. Its sequence forms stable complexes with selected MHC class I molecules. Researchers employ it to dissect antigen processing, presentation, and cross-reactivity. The peptide aids benchmarking of antiviral epitope recognition assays.
CAT No: V06006
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Emu oil in combination with other active ingredients for treating skin imperfections
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More